THAR: Tharimmune, Inc. Stock

by  •  • Comments Off on THAR: Tharimmune, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 2.32
Enterprise Value ($M) -1.24
Book Value ($M) 1.31
Book Value / Share 0.62
Price / Book 1.77
NCAV ($M) 1.31
NCAV / Share 0.62
Price / NCAV 1.77

Profitability (mra)
Return on Invested Capital (ROIC) -9.33
Return on Assets (ROA) -1.37
Return on Equity (ROE) -1.73

Liquidity (mrq)
Quick Ratio 1.54
Current Ratio 1.54

Balance Sheet (mrq) ($M)
Current Assets 3.72
Assets 3.72
Liabilities 2.41
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -12.43
Net Income -12.20
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -10.90
Cash from Investing 0.00
Cash from Financing 3.53

(click for more detail)
Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-26 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 3,253 4,095 79.44
2025-04-16 887 3,823 23.20
2025-04-15 1,908 10,389 18.37
2025-04-14 2,320 8,769 26.46

(click for more detail)

Similar Companies
TELO – Telomir Pharmaceuticals, Inc. TENX – Tenax Therapeutics, Inc.
TGTX – TG Therapeutics, Inc. THTX – Theratechnologies Inc.
TIL – Instil Bio, Inc.


Financial data and stock pages provided by
Fintel.io